Diabetes entails a collection of metabolic disorders which are usually characterized by prolonged high sugar levels in an individual’s blood. For instance, both type 1 diabetes (T1D) and type 2 diabetes (T2D) are characterized with hyperglycemia. This condition is referred as hyperglycemia, and it has been found to cause debilitating health consequences. Van Belle, Coppieters and von Herrath (2011) report reaffirm that chronic hyperglycemic conditions may lead to health complications including heart disease, blindness, kidney failure, stroke, and ketoacidosis. Ordinarily, T2D occurs due to insulin resistance in which adipose or muscle cells exhibit low response to insulin. This phenomenon is associated to old age or obesity. In contrast, T1D is caused by autoimmune destruction of pancreatic beta-cells which are responsible for the production of insulin (Ozougwu, Obimba, Belonwu & Unakalamba, 2013). Currently, diabetes presents an immense challenge to the global public health system (Kimuyu, 2018). Therefore, this discussion focuses on the key aspects of type 1 diabetes.
Table of Contents
Introduction
Epidemiology
Impact of T1D on Life
Disease Process
Signs of T1D
Etiology of T1D
Genetics of T1D
Cause of Beta Cells Destruction
Environmental Triggers
Nutritional Triggers of T1D
Protective Dietary Components
Pathophysiology of T1D
Effect of T1D on Body Systems
Conclusion
Research Objectives and Core Themes
This work aims to provide a comprehensive analysis of Type 1 Diabetes (T1D) by examining its underlying physiological mechanisms, genetic foundations, and the various environmental and nutritional factors that contribute to the disease's progression.
- Autoimmune destruction of pancreatic beta-cells
- Genetic predisposition and the role of specific gene mutations
- Environmental triggers including microbial imbalances and viral infections
- Nutritional impact on autoimmune development
- Pathophysiological consequences and effects on major body systems
Excerpt from the Book
Genetics of T1D
Being at autoimmune disorder, T1D occurs due to changes in the genetic components in an individual’s genome. Genetic mutations in the chromosomal regions involved in the production of insulin-producing genes. According to Chiang, Kirkman, Laffel and Peters (2014), there is an array of genes involved in the etiology of T1D. These include a rare monogenic forms, HLA gene, insulin gene, PTPN22 gene, IL2RA gene, and CTLA-4 gene. It is reported that T1D, hardly occurs due the mutation of a single gene, but rather a collection of genetic defects. In most cases, a single mutation combines with other autoimmune factors that are involved in the regulatory pathway to cause the disorder. For instance, genetic changes in Foxp3 transcription factor impairs the regulation of T cells; thus, leading to multiorgan autoimmunity.
This phenomenon is evidenced in IPEX syndrome, as well as autoimmune polyendocrine syndrome type 1. It is estimated that 80% of children with Foxp3 mutations die early due the severity of the autoimmunity. On the other hand, genetic changes in autoimmune regulator (AIRE) have been found to cause 20% of T1D (Van Belle, Coppieters & von Herrath, 2011). Genetic changes in HLA gene have also been found to be responsible for the onset of T1D (Todd, 2010). Research indicates that more than 60% of patients with T1D posses a mutant form of HLA gene, HLA-A *0201, which increases the susceptibility for T1D. On the other hand, genetic changes in the insulin gene locus have been found to predispose individuals to T1D. Tandem repeats of VNTR type I on insulin gene locus, located on chromosome 11 impair the binding of AIRE to the promoter region, leading dysregulation. In this context, clinical studies indicate that VNTR type I is responsible for the reduced tolerance in the thymus, which is in turn caused by low transcription of insulin protein.
Summary of Chapters
Introduction: Defines diabetes as a metabolic disorder characterized by hyperglycemia and distinguishes between Type 1 and Type 2 diabetes.
Epidemiology: Discusses the prevalence of T1D, specifically noting its higher incidence among children and demographic disparities in the US.
Impact of T1D on Life: Examines how the disease adversely affects life expectancy, social interactions, and the mental well-being of patients.
Disease Process: Explains the mechanism of progressive autoimmune destruction of pancreatic beta-cells leading to insulin deficiency.
Signs of T1D: Identifies primary symptoms such as polyphagia, polyuria, ketonemia, and polydipsia.
Etiology of T1D: Introduces the multifactorial origins of T1D, highlighting the interplay between genetic and environmental factors.
Genetics of T1D: Details specific gene mutations, such as HLA and insulin gene loci, that contribute to the autoimmune response.
Cause of Beta Cells Destruction: Analyzes the pathological role of autoreactive T cells that escape elimination in the thymus.
Environmental Triggers: Investigates how bacterial and viral infections can precipitate T1D onset.
Nutritional Triggers of T1D: Explores how components like cow's milk and gluten can trigger autoimmune reactions in susceptible infants.
Protective Dietary Components: Highlights the potential role of nutrients like Vitamin D in protecting beta cells.
Pathophysiology of T1D: Describes how insulin deficiency and abnormal glucagon levels lead to metabolic shifts like ketoacidosis.
Effect of T1D on Body Systems: Outlines the systemic damage caused by T1D, including impacts on the kidneys, digestive, and circulatory systems.
Conclusion: Summarizes the autoimmune nature of the disease and suggests future research directions toward vitamin D analogs.
Keywords
Type 1 Diabetes, Autoimmune destruction, Beta-cells, Insulin deficiency, Hyperglycemia, Genetics, HLA gene, Environmental triggers, Nutritional triggers, Pathophysiology, Ketoacidosis, Metabolic disorders, Polyphagia, Polyuria, Polydipsia.
Frequently Asked Questions
What is the fundamental focus of this publication?
This work provides an in-depth examination of Type 1 Diabetes (T1D), focusing on its physiological mechanisms, etiology, and the various factors that influence its progression from a medical and scientific perspective.
Which thematic areas are primarily covered?
The text covers the epidemiology of T1D, the underlying genetic causes, environmental and nutritional triggers, the pathological process of beta-cell destruction, and the long-term effects on various human body systems.
What is the primary research objective?
The objective is to explain how T1D develops through a combination of genetic predisposition and external triggers, and to detail how this leads to the systemic health complications observed in patients.
Which scientific methodology is employed?
The work utilizes a review of existing clinical literature and epidemiological models to synthesize current knowledge regarding the pathology and etiology of Type 1 Diabetes.
What topics are discussed in the main body?
The main body treats the disease process, the specific roles of genes like HLA and PTPN22, the impact of viruses and bacteria, dietary influences, and the resulting physiological imbalances like ketoacidosis.
Which keywords characterize this document?
Key terms include Type 1 Diabetes, autoimmune destruction, beta-cells, insulin, hyperglycemia, genetic predisposition, and various metabolic symptoms.
How does cow's milk influence T1D development?
The text suggests that certain proteins in cow's milk can cross-react with beta-cell surface proteins in infants, potentially triggering an autoimmune response that predisposes them to T1D.
What is the role of the AIRE gene in T1D?
The Autoimmune Regulator (AIRE) gene is crucial for self-tolerance; mutations in or impaired binding of AIRE leads to reduced tolerance in the thymus, contributing to the development of autoreactive T cells that destroy beta-cells.
- Arbeit zitieren
- Patrick Kimuyu (Autor:in), 2018, Understanding Type I Diabetes and the Underlying Physiological Mechanisms, München, GRIN Verlag, https://www.grin.com/document/411946
